Friedlander, M. L., Moore, K. N., Colombo, N., Scambia, G., Kim, B., Oaknin, A., Lisyanskaya, A., Floquet, A., Leary, A., Sonke, G. S., Gourley, C., Banerjee, S., Oza, A., González-Martín, A., Aghajanian, C., Bradley, W., Lowe, E., Hettle, R., Flood, E., & Disilvestro, P. (n.d.). 224OPatient-centred outcomes with maintenance olaparib in newly diagnosed patients with advanced ovarian cancer (OC) and a BRCA mutation in the phase III SOLO1 trial to support the clinical benefit of prolongation of progression-free survival (PFS). Annals of oncology, 30, . http://access.bl.uk/ark:/81055/vdc_100098040153.0x00002f